Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.
Johnson
J A
JA
School of Public Health, University of Alberta, Edmonton, AB, Canada. jeff.johnson@ualberta.ca
Yasui
Y
Y
D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin